Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382:819–31.
Hassan AB, Lundberg IE, Isenberg D, et al. Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31:133–9.
Pourmand N, Wahren-Herlenius M, Gunnarsson I, et al. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjogren's syndrome and systemic lupus erythematosus. Ann Rheum Dis. 1999;58:623–9.
Popovic K, Nyberg F, Wahren-Herlenius M, et al. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum. 2007;56:255–64.
Eloranta ML, Ronnblom L. Cause and consequences of the activated type I interferon system in SLE. J Mol Med. 2016;94:1103–10.
Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2:777–80.
Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308–18.
Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–55.
Kvarnstrom M, Ottosson V, Nordmark B, et al. Incident cases of primary Sjogren’s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand J Rheumatol. 2015;44:135–42.
Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford). 2013;52:2108–15.
Simard JF, Sjowall C, Ronnblom L, et al. Systemic lupus erythematosus prevalence in Sweden in 2010: what do national registers say? Arthritis Care Res. 2014;66:1710–7.
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38.
McMurray RW, May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum. 2003;48:2100–10.
Liu K, Kurien BT, Zimmerman SL, et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjogren’s syndrome. Arthritis Rheum. 2016;68:1290–300.
Yao C, Joehanes R, Johnson AD, et al. Sex- and age-interacting eQTLs in human complex diseases. Hum Mol Genet. 2014;23:1947–56.
Parks CG, De Roos AJ. Pesticides, chemical and industrial exposures in relation to systemic lupus Erythematosus. Lupus. 2014;23:527–36.
Gomez A, Luckey D, Taneja V. The gut microbiome in autoimmunity: sex matters. Clin Immunol. 2015;159:154–62.
Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009;11:R7.
Marrie RA, Patten SB, Tremlett H, et al. Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study. Neurology. 2016;86:1279–86.
Hussein H, Lee P, Chau C, et al. The effect of male sex on survival in systemic sclerosis. J Rheumatol. 2014;41:2193–200.
Ramirez Sepulveda JI, Kvarnstrom M, Brauner S, et al. Difference in clinical presentation between women and men in incident primary Sjogren’s syndrome. Biol Sex Differ. 2017;8:16.
Ramirez Sepulveda JI, Kvarnstrom M, Eriksson P, et al. Long-term follow-up in primary Sjogren’s syndrome reveals differences in clinical presentation between female and male patients. Biol Sex Differ. 2017;8:25.
Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol. 2012;2012:604892.
Andrade RM, Alarcon GS, Fernandez M, et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007;56:622–30.
Manger K, Manger B, Repp R, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61:1065–70.
Austin HA 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983;75:382–91.
Iseki K, Miyasato F, Oura T, et al. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis. 1994;23:547–54.
de Carvalho JF. do Nascimento, AP, Testagrossa, LA, et al. Male gender results in more severe lupus nephritis. Rheumatol Int. 2010;30:1311–5.
Yu KH, Kuo CF, Chou IJ, et al. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study. Int J Rheum Dis. 2016;19:1175–82.
Al Arfaj AS, Khalil N, Al Saleh S. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int. 2009;29:1057–67.
Mok CC, Wong RW, Lau CS. Lupus nephritis in southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis. 1999;34:315–23.
Mok CC. Prognostic factors in lupus Nephritis. Lupus. 2005;14:39–44.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
Fries JF, Holman HR. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med. 1975;6:v–199.
Churg J. Renal disease : classification and atlas of glomerular disease. 2nd ed. New York: Igaku-Shoin; 1995. p. 1–541.
Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521–30.
Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol. 2009;36:131–40.
Alonso MD, Martinez-Vazquez F, Riancho-Zarrabeitia L, et al. Sex differences in patients with systemic lupus erythematosus from Northwest Spain. Rheumatol Int. 2014;34:11–24.
Crosslin KL, Wiginton KL. Sex differences in disease severity among patients with systemic lupus erythematosus. Gend Med. 2011;8:365–71.
Lu LJ, Wallace DJ, Ishimori ML, et al. Review: male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus. 2010;19:119–29.
Voulgari PV, Katsimbri P, Alamanos Y, et al. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus. 2002;11:722–9.
Vozmediano C, Rivera F, Lopez-Gomez JM, et al. Risk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis. Nephron Extra. 2012;2:269–77.
Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11:329–41.
Bolin K, Sandling JK, Zickert A, et al. Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS One. 2013;8:e84450.
Mok CC, Kwok RC, Yip PS. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum. 2013;65:2154–60.
Gustafsson JT, Simard JF, Gunnarsson I, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther. 2012;14:R46.
Feldman CH, Broder A, Guan H, et al. Sex differences in health care utilization, end-stage renal disease, and mortality among Medicaid beneficiaries with incident lupus nephritis. Arthritis Rheum. 2018;70:417–26.
Aydintug AO, Domenech I, Cervera R, et al. Systemic lupus erythematosus in males: analysis of clinical and laboratory features. Lupus. 1992;1:295–8.
Font J, Cervera R, Navarro M, et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis. 1992;51:1050–2.
Liang Y, Leng RX, Pan HF, et al. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatol Int. 2017;37:305–11.
Im CH, Park JA, Kim JY, et al. CXCR3 polymorphism is associated with male gender and pleuritis in patients with systemic lupus erythematosus. Hum Immunol. 2014;75:466–9.
Balbir-Gurman A, Yigla M, Nahir AM, et al. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006;35:368–78.
Durosaro O, Davis MD, Reed KB, et al. Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol. 2009;145:249–53.
Jarukitsopa S, Hoganson DD, Crowson CS, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res. 2015;67:817–28.